Mirion Finishes $100 Million Buyback, Starts $250 Million One As Goodwill Stays Under Watch

Treasury stock reached $160.3 million at September 30, up from $103.7 million at June 30, while goodwill stands at $1,859.5 million.

Share
Mirion Finishes $100 Million Buyback, Starts $250 Million One As Goodwill Stays Under Watch

Mirion Technologies, which makes radiation detection, measurement and monitoring products, completed its $100 million share buyback in the third quarter and started a new $250 million program, according to its 10-Q filed Wednesday. The same filing says rising long-term interest rates and trade risks could eventually force a goodwill write-down.

One buyback ends, another begins

The 2024 program, which began repurchases in February 2025, retired 5,937,716 Class A shares for $100.0 million in total. The board approved the new $250 million authorization on August 31, 2026, and it runs through August 31, 2031.

Under the new program, Mirion had bought 963,371 shares for $15.4 million by September 30.

Treasury stock stood at $160.3 million at quarter-end, up from $103.7 million at June 30. Cash spent on buying stock for the nine months was $96.8 million, against $49.6 million a year earlier.

Goodwill of $1,859.5 million

Goodwill, the premium Mirion paid over the net assets of businesses it bought, is $1,859.5 million. Nuclear & Safety carries $1,225.5 million of it and Medical $634.0 million.

No event in the third quarter triggered an interim impairment test. Management flagged higher long-term rates and trade-related geopolitical risk as possible causes of a future write-down at one or more reporting units. The required annual test for all units comes in the fourth quarter of 2026.

Cash flow funds the repurchases

Operating cash flow for the nine months rose to $136.6 million from $70.3 million. Revenue for the third quarter was $277.8 million versus $223.1 million a year earlier, and net income was $7.8 million versus $3.1 million.

Mirion's Nuclear & Safety segment serves nuclear plants, labs and defense customers. Its Medical segment sells cancer-care quality assurance tools and dosimetry, which tracks radiation doses absorbed by workers. The company bought Paragon for $588.6 million on December 1, 2025.

Backlog tied to Russian projects and Chinese parts and services contracts was about $163.4 million at September 30. The prior quarter's filing put a similar Russian- and Chinese-related figure at $124.0 million at June 30.

Mirion's annual goodwill test is due in the fourth quarter of 2026, and the $250 million buyback has authority to run through August 31, 2031.

Sources

More on Mirion Technologies

All Mirion Technologies (MIR) coverage →